Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 36,470 shares at $39.33 ($1.4M) on 2024-03-20, disclosed to the SEC on 2024-03-22.
Open-market sale of $1.4M RYTM by EVP, Head of North America. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.22 | 9,169 | $350K | 24.8% |
| 2 | $38.22 | 9,169 | $350K | 24.8% |
| 3 | $39.33 | 9,066 | $357K | 25.2% |
| 4 | $39.33 | 9,066 | $357K | 25.2% |
| Total | $38.77 avg | 36,470 | $1.4M | 100% |
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |